- Home
- INFU vs TVGN Comparison
INFU vs TVGN Comparison
Compare INFU & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- TVGN
- Stock Information
- Founded
- INFU 2005
- TVGN 2020
- Country
- INFU United States
- TVGN United States
- Employees
- INFU N/A
- TVGN N/A
- Industry
- INFU Medical/Dental Instruments
- TVGN Blank Checks
- Sector
- INFU Health Care
- TVGN Finance
- Exchange
- INFU Nasdaq
- TVGN Nasdaq
- Market Cap
- INFU 180.4M
- TVGN 179.0M
- IPO Year
- INFU N/A
- TVGN N/A
- Fundamental
- Price
- INFU $9.75
- TVGN $0.84
- Analyst Decision
- INFU Strong Buy
- TVGN Strong Buy
- Analyst Count
- INFU 1
- TVGN 1
- Target Price
- INFU $12.00
- TVGN $10.00
- AVG Volume (30 Days)
- INFU 301.2K
- TVGN 484.0K
- Earning Date
- INFU 11-06-2025
- TVGN 08-14-2025
- Dividend Yield
- INFU N/A
- TVGN N/A
- EPS Growth
- INFU 2168.02
- TVGN N/A
- EPS
- INFU 0.24
- TVGN N/A
- Revenue
- INFU $139,886,000.00
- TVGN N/A
- Revenue This Year
- INFU $9.07
- TVGN N/A
- Revenue Next Year
- INFU $6.55
- TVGN N/A
- P/E Ratio
- INFU $41.71
- TVGN N/A
- Revenue Growth
- INFU 8.13
- TVGN N/A
- 52 Week Low
- INFU $4.61
- TVGN $0.26
- 52 Week High
- INFU $11.04
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- INFU 53.52
- TVGN 33.66
- Support Level
- INFU $9.82
- TVGN $0.86
- Resistance Level
- INFU $10.33
- TVGN $0.99
- Average True Range (ATR)
- INFU 0.39
- TVGN 0.05
- MACD
- INFU -0.20
- TVGN 0.00
- Stochastic Oscillator
- INFU 1.53
- TVGN 0.00
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.